Chronic liver diseases such as hepatitis, liver cirrhosis, and hepatocellular carcinoma are a major cause of morbidity and mortality worldwide. Fibrosis—the thickening and scarring of connective ...
Please provide your email address to receive an email when new articles are posted on . Treatment responders demonstrated significant reductions in iron corrected T1 and liver fat content. Optimal ...
Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through ...
MedPage Today on MSN
Enhanced MRI tops ultrasound in catching early liver cancer
MRI approach also led to fewer false referrals ...
WASHINGTON & OXFORD, England--(BUSINESS WIRE)--Perspectum announced two research studies that were recently published, bringing hope to people with metabolic dysfunction-associated steatohepatitis ...
Dr. Jason Chiang and Dr. Kyung Sung of the department of radiological sciences at the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center have received a $3 ...
Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...
India, June 2 -- A large multicenter clinical trial has found that individuals with hepatic steatosis-commonly known as fatty ...
Hepatic hypodensities are areas on the liver that appear darker on imaging tests like CT scans. They mean there is a difference in that area of tissue in the liver. These areas can be caused by a ...
Mindray, a global leader in healthcare innovation across perioperative, medical imaging, and critical care, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results